Uses AI to: Process raw phenotypic, imaging, drug, and genomic data sets. Allows researchers to: Integrate rapid analytics and machine learning capabilities into existing business processes to improve care, enhance discoveries, gain insight into business, and enable fast data-driven decisions.
This report contains market size and forecasts of Artificial Intelligence (AI) in Drug Discovery in Global, including the following market information:
Global Artificial Intelligence (AI) in Drug Discovery Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Artificial Intelligence (AI) in Drug Discovery market was valued at 780.2 million in 2021 and is projected to reach US$ 3053.7 million by 2028, at a CAGR of 21.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Software Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Artificial Intelligence (AI) in Drug Discovery include IBM, Microsoft, Google, NVIDIA Corporation, Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Insilico Medicine and BenevolentAI, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Artificial Intelligence (AI) in Drug Discovery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Artificial Intelligence (AI) in Drug Discovery Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Artificial Intelligence (AI) in Drug Discovery Market Segment Percentages, by Type, 2021 (%)
Software
Services
Global Artificial Intelligence (AI) in Drug Discovery Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Artificial Intelligence (AI) in Drug Discovery Market Segment Percentages, by Application, 2021 (%)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Research Centers and Academic & Government Institutes
Global Artificial Intelligence (AI) in Drug Discovery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Artificial Intelligence (AI) in Drug Discovery Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Artificial Intelligence (AI) in Drug Discovery revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Artificial Intelligence (AI) in Drug Discovery revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
IBM
Microsoft
Google
NVIDIA Corporation
Atomwise, Inc.
Deep Genomics
Cloud Pharmaceuticals
Insilico Medicine
BenevolentAI
Exscientia
Cyclica
BIOAGE
Numerate
NuMedii
Envisagenics
twoXAR
OWKIN, Inc.
XtalPi
Verge Genomics
BERG LLC